![Infinity Pharmaceuticals Inc](/common/images/company/N_INFI.png)
Infinity Pharmaceuticals, Inc. (Nasdaq: INFI) (“Infinity” or the “Company”), a clinical-stage biotechnology company developing eganelisib, a potential first-in-class, oral, immuno-oncology...
Eganelisib Remains Primary Value Driver for Infinity Infinity to Explore Strategic Alternatives to Maximize Value for Stockholders Infinity Pharmaceuticals, Inc. (Nasdaq: INFI) (“Infinity”), a...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | -0.1007 | -75.7712565839 | 0.1329 | 0.1863 | 0.0233 | 6209940 | 0.11004957 | CS |
156 | -2.2778 | -98.6060606061 | 2.31 | 3.89 | 0.0233 | 1620623 | 1.40260041 | CS |
260 | -1.5578 | -97.9748427673 | 1.59 | 5.98 | 0.0233 | 1514611 | 2.04373385 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.